Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Saved in:
| Title: | Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database. |
|---|---|
| Authors: | Tanni KA; Department of Health Outcomes Research and Policy, Auburn University Harrison School of Pharmacy, Auburn, AL, USA., Truong CB; Department of Health Outcomes Research and Policy, Auburn University Harrison School of Pharmacy, Auburn, AL, USA., Almahasis S; Department of Health Outcomes Research and Policy, Auburn University Harrison School of Pharmacy, Auburn, AL, USA., Qian J; Department of Health Outcomes Research and Policy, Auburn University Harrison School of Pharmacy, Auburn, AL, USA. jzq0004@auburn.edu. |
| Source: | BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2021 Mar; Vol. 35 (2), pp. 239-254. Date of Electronic Publication: 2021 Jan 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-190X (Electronic) Linking ISSN: 11738804 NLM ISO Abbreviation: BioDrugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1179-190X |
|---|---|
| DOI: | 10.1007/s40259-020-00466-3 |
